Variant position: 389 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 412 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LYNEELVSMNVQGDYEPTDA TGFININSLRLKEYHRLQSKV
Mouse LYNEELVSMNVQGDYEPIDA TGFININSLRLKEYHRLQSKV
Rat LYNEELVSMNVQGDYEPIDA TGFININSLRLKEYHRLQSKV
Bovine LYNEELVSMNVQGDYEPVDA TGFININSLRLKEYHRLQNKV
Chicken LYNEELVSMDVQGDYEPADA TGFININALRLKEYHRLQSKV
Xenopus laevis LYNEELVSMDVQGDYDPADA CGFIKINAVRLKEYHRLQKNK
Xenopus tropicalis LYNEELVSMDVQGDYDPADA CGFIRINALRLKEFHRLQKSK
Zebrafish LYNEELVSMDVQGDYDPCDA SGFIKINAVRLREHNRLQGAA
Drosophila LYNEQLVSMDVHGGYVPQDA GGFIAINAVRIREHVRAFGAY
Baker's yeast LYDPTESSMDELTGFLPTDT TGFIAIQAIRIKKYGESKKTK
Fission yeast LYDEKLSSMDELGGFDPTWT SGFIQIESMRLRNSDEGKHWM
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 412 Argininosuccinate synthase
385 – 404
Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patients.
Gao H.-Z.; Kobayashi K.; Tabata A.; Tsuge H.; Iijima M.; Yasuda T.; Kalkanoglu H.S.; Dursun A.; Tokatli A.; Coskun T.; Trefz F.K.; Skladal D.; Mandel H.; Seidel J.; Kodama S.; Shirane S.; Ichida T.; Makino S.; Yoshino M.; Kang J.-H.; Mizuguchi M.; Barshop B.A.; Fuchinoue S.; Seneca S.; Zeesman S.; Knerr I.; Rodes M.; Wasant P.; Yoshida I.; De Meirleir L.; Abdul-Jalil M.; Begum L.; Horiuchi M.; Katunuma N.; Nakagawa S.; Saheki T.;
Hum. Mutat. 22:24-34(2003)
Cited for: VARIANTS CTLN1 ARG-19; HIS-86; SER-95; SER-96; ASP-117; SER-117; CYS-157; ARG-179; LYS-191; HIS-265; MET-269; CYS-272; LYS-283; TRP-304; GLN-310; SER-324; VAL-362; GLN-363; TRP-363; ILE-389 AND ARG-390;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.